?>
Plan Name | WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST |
Plan identification number | 010 |
Company Name: | WEST PHARMACEUTICAL SERVICES, INC. |
Employer identification number (EIN): | 231210010 |
NAIC Classification: | 339110 |
Additional information about WEST PHARMACEUTICAL SERVICES, INC.
Jurisdiction of Incorporation: | Texas Secretary of State |
Incorporation Date: | 1990-06-01 |
Company Identification Number: | 0008421106 |
Legal Registered Office Address: |
101 GORDON DR EXTON United States of America (USA) 19341 |
More information about WEST PHARMACEUTICAL SERVICES, INC.
Plan id# | Filing Submission Date | Name of Administrator | Date Administrator Signed | Name of Company Sponsor | Date Sponsor Signed |
---|---|---|---|---|---|
010 | 2022-01-01 | ||||
010 | 2021-01-01 | ||||
010 | 2020-01-01 | ||||
010 | 2019-01-01 | ||||
010 | 2018-01-01 | ANNETTE FAVORITE | ANNETTE FAVORITE | 2019-07-22 | |
010 | 2017-01-01 | 2018-06-29 | |||
010 | 2016-01-01 | 2017-07-13 | |||
010 | 2015-01-01 | ANNETTE FAVORITE | ANNETTE FAVORITE | 2016-07-27 | |
010 | 2014-01-01 | 2015-07-30 | |||
010 | 2013-01-01 | 2014-07-23 | |||
010 | 2012-01-01 | RICHARD D. LUZZI | RICHARD D. LUZZI | 2013-07-22 | |
010 | 2011-01-03 | RICHARD D. LUZZI | RICHARD D. LUZZI | 2012-09-25 |
Measure | Date | Value |
---|---|---|
2022 : WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2022 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2022-12-31 | $-49,950,119 |
Total unrealized appreciation/depreciation of assets | 2022-12-31 | $-49,950,119 |
Total transfer of assets from this plan | 2022-12-31 | $10,864,695 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
Total income from all sources (including contributions) | 2022-12-31 | $-53,756,430 |
Total loss/gain on sale of assets | 2022-12-31 | $-3,972,859 |
Total of all expenses incurred | 2022-12-31 | $0 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $0 |
Value of total assets at end of year | 2022-12-31 | $50,380,941 |
Value of total assets at beginning of year | 2022-12-31 | $115,002,066 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $0 |
Total interest from all sources | 2022-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $166,548 |
Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
Value of net income/loss | 2022-12-31 | $-53,756,430 |
Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $50,380,941 |
Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $115,002,066 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | No |
Assets. Invements in employer securities at end of year | 2022-12-31 | $50,380,941 |
Assets. Invements in employer securities at beginning of year | 2022-12-31 | $115,002,066 |
Income. Dividends from common stock | 2022-12-31 | $166,548 |
Did the plan have assets held for investment | 2022-12-31 | Yes |
Aggregate proceeds on sale of assets | 2022-12-31 | $10,698,147 |
Aggregate carrying amount (costs) on sale of assets | 2022-12-31 | $14,671,006 |
2021 : WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2021 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2021-12-31 | $45,066,811 |
Total unrealized appreciation/depreciation of assets | 2021-12-31 | $45,066,811 |
Total transfer of assets to this plan | 2021-12-31 | $535,512 |
Total transfer of assets from this plan | 2021-12-31 | $21,675,162 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
Total income from all sources (including contributions) | 2021-12-31 | $50,485,255 |
Total loss/gain on sale of assets | 2021-12-31 | $5,227,801 |
Total of all expenses incurred | 2021-12-31 | $0 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $0 |
Value of total assets at end of year | 2021-12-31 | $115,002,066 |
Value of total assets at beginning of year | 2021-12-31 | $85,656,461 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $0 |
Total interest from all sources | 2021-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $190,643 |
Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
Value of net income/loss | 2021-12-31 | $50,485,255 |
Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $115,002,066 |
Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $85,656,461 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
Assets. Invements in employer securities at end of year | 2021-12-31 | $115,002,066 |
Assets. Invements in employer securities at beginning of year | 2021-12-31 | $85,656,461 |
Income. Dividends from common stock | 2021-12-31 | $190,643 |
Did the plan have assets held for investment | 2021-12-31 | Yes |
Aggregate proceeds on sale of assets | 2021-12-31 | $23,039,588 |
Aggregate carrying amount (costs) on sale of assets | 2021-12-31 | $17,811,787 |
2020 : WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2020 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2020-12-31 | $39,639,071 |
Total unrealized appreciation/depreciation of assets | 2020-12-31 | $39,639,071 |
Total transfer of assets to this plan | 2020-12-31 | $477,275 |
Total transfer of assets from this plan | 2020-12-31 | $10,632,342 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Total income from all sources (including contributions) | 2020-12-31 | $43,136,614 |
Total loss/gain on sale of assets | 2020-12-31 | $3,288,378 |
Total of all expenses incurred | 2020-12-31 | $0 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $0 |
Value of total assets at end of year | 2020-12-31 | $85,656,461 |
Value of total assets at beginning of year | 2020-12-31 | $52,674,914 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $0 |
Total interest from all sources | 2020-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $209,165 |
Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
Value of net income/loss | 2020-12-31 | $43,136,614 |
Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $85,656,461 |
Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $52,674,914 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
Assets. Invements in employer securities at end of year | 2020-12-31 | $85,656,461 |
Assets. Invements in employer securities at beginning of year | 2020-12-31 | $52,674,914 |
Income. Dividends from common stock | 2020-12-31 | $209,165 |
Did the plan have assets held for investment | 2020-12-31 | Yes |
Aggregate proceeds on sale of assets | 2020-12-31 | $12,085,005 |
Aggregate carrying amount (costs) on sale of assets | 2020-12-31 | $8,796,627 |
2019 : WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2019 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2019-12-31 | $18,037,955 |
Total unrealized appreciation/depreciation of assets | 2019-12-31 | $18,037,955 |
Total transfer of assets to this plan | 2019-12-31 | $487,617 |
Total transfer of assets from this plan | 2019-12-31 | $7,191,765 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Total income from all sources (including contributions) | 2019-12-31 | $19,996,673 |
Total loss/gain on sale of assets | 2019-12-31 | $1,727,233 |
Total of all expenses incurred | 2019-12-31 | $0 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $0 |
Value of total assets at end of year | 2019-12-31 | $52,674,914 |
Value of total assets at beginning of year | 2019-12-31 | $39,382,389 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $0 |
Total interest from all sources | 2019-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $231,485 |
Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
Value of net income/loss | 2019-12-31 | $19,996,673 |
Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $52,674,914 |
Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $39,382,389 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | No |
Assets. Invements in employer securities at end of year | 2019-12-31 | $52,674,914 |
Assets. Invements in employer securities at beginning of year | 2019-12-31 | $39,382,389 |
Income. Dividends from common stock | 2019-12-31 | $231,485 |
Did the plan have assets held for investment | 2019-12-31 | Yes |
Aggregate proceeds on sale of assets | 2019-12-31 | $7,991,387 |
Aggregate carrying amount (costs) on sale of assets | 2019-12-31 | $6,264,154 |
2018 : WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2018 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2018-12-31 | $-464,306 |
Total unrealized appreciation/depreciation of assets | 2018-12-31 | $-464,306 |
Total transfer of assets to this plan | 2018-12-31 | $545,114 |
Total transfer of assets from this plan | 2018-12-31 | $5,807,285 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $0 |
Total income from all sources (including contributions) | 2018-12-31 | $83,910 |
Total loss/gain on sale of assets | 2018-12-31 | $306,677 |
Total of all expenses incurred | 2018-12-31 | $0 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2018-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2018-12-31 | $0 |
Value of total assets at end of year | 2018-12-31 | $39,382,389 |
Value of total assets at beginning of year | 2018-12-31 | $44,560,650 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2018-12-31 | $0 |
Total interest from all sources | 2018-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2018-12-31 | $241,539 |
Were there any nonexempt tranactions with any party-in-interest | 2018-12-31 | No |
Value of net income/loss | 2018-12-31 | $83,910 |
Value of net assets at end of year (total assets less liabilities) | 2018-12-31 | $39,382,389 |
Value of net assets at beginning of year (total assets less liabilities) | 2018-12-31 | $44,560,650 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2018-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2018-12-31 | No |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2018-12-31 | No |
Assets. Invements in employer securities at end of year | 2018-12-31 | $39,382,389 |
Assets. Invements in employer securities at beginning of year | 2018-12-31 | $44,560,650 |
Income. Dividends from common stock | 2018-12-31 | $241,539 |
Did the plan have assets held for investment | 2018-12-31 | Yes |
Aggregate proceeds on sale of assets | 2018-12-31 | $6,518,045 |
Aggregate carrying amount (costs) on sale of assets | 2018-12-31 | $6,211,368 |
2017 : WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2017 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2017-12-31 | $5,895,237 |
Total unrealized appreciation/depreciation of assets | 2017-12-31 | $5,895,237 |
Total transfer of assets to this plan | 2017-12-31 | $482,702 |
Total transfer of assets from this plan | 2017-12-31 | $8,625,893 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $0 |
Total income from all sources (including contributions) | 2017-12-31 | $6,936,084 |
Total loss/gain on sale of assets | 2017-12-31 | $774,854 |
Total of all expenses incurred | 2017-12-31 | $0 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2017-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2017-12-31 | $0 |
Value of total assets at end of year | 2017-12-31 | $44,560,650 |
Value of total assets at beginning of year | 2017-12-31 | $45,767,757 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2017-12-31 | $0 |
Total interest from all sources | 2017-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2017-12-31 | $265,993 |
Were there any nonexempt tranactions with any party-in-interest | 2017-12-31 | No |
Value of net income/loss | 2017-12-31 | $6,936,084 |
Value of net assets at end of year (total assets less liabilities) | 2017-12-31 | $44,560,650 |
Value of net assets at beginning of year (total assets less liabilities) | 2017-12-31 | $45,767,757 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2017-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2017-12-31 | No |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2017-12-31 | No |
Assets. Invements in employer securities at end of year | 2017-12-31 | $44,560,650 |
Assets. Invements in employer securities at beginning of year | 2017-12-31 | $45,767,757 |
Income. Dividends from common stock | 2017-12-31 | $265,993 |
Did the plan have assets held for investment | 2017-12-31 | Yes |
Aggregate proceeds on sale of assets | 2017-12-31 | $9,265,138 |
Aggregate carrying amount (costs) on sale of assets | 2017-12-31 | $8,490,284 |
2016 : WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2016 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2016-12-31 | $13,036,167 |
Total unrealized appreciation/depreciation of assets | 2016-12-31 | $13,036,167 |
Total transfer of assets to this plan | 2016-12-31 | $476,201 |
Total transfer of assets from this plan | 2016-12-31 | $6,408,658 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $0 |
Total income from all sources (including contributions) | 2016-12-31 | $14,630,699 |
Total loss/gain on sale of assets | 2016-12-31 | $1,309,536 |
Total of all expenses incurred | 2016-12-31 | $0 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2016-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2016-12-31 | $0 |
Value of total assets at end of year | 2016-12-31 | $45,767,757 |
Value of total assets at beginning of year | 2016-12-31 | $37,069,515 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2016-12-31 | $0 |
Total interest from all sources | 2016-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2016-12-31 | $284,996 |
Were there any nonexempt tranactions with any party-in-interest | 2016-12-31 | No |
Value of net income/loss | 2016-12-31 | $14,630,699 |
Value of net assets at end of year (total assets less liabilities) | 2016-12-31 | $45,767,757 |
Value of net assets at beginning of year (total assets less liabilities) | 2016-12-31 | $37,069,515 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2016-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2016-12-31 | No |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2016-12-31 | No |
Assets. Invements in employer securities at end of year | 2016-12-31 | $45,767,757 |
Assets. Invements in employer securities at beginning of year | 2016-12-31 | $37,069,515 |
Income. Dividends from common stock | 2016-12-31 | $284,996 |
Did the plan have assets held for investment | 2016-12-31 | Yes |
Aggregate proceeds on sale of assets | 2016-12-31 | $7,170,788 |
Aggregate carrying amount (costs) on sale of assets | 2016-12-31 | $5,861,252 |
2015 : WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2015 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2015-12-31 | $4,223,519 |
Total unrealized appreciation/depreciation of assets | 2015-12-31 | $4,223,519 |
Total transfer of assets to this plan | 2015-12-31 | $315,681 |
Total transfer of assets from this plan | 2015-12-31 | $6,125,477 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-12-31 | $0 |
Total income from all sources (including contributions) | 2015-12-31 | $4,876,312 |
Total loss/gain on sale of assets | 2015-12-31 | $353,828 |
Total of all expenses incurred | 2015-12-31 | $0 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2015-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2015-12-31 | $0 |
Value of total assets at end of year | 2015-12-31 | $37,069,515 |
Value of total assets at beginning of year | 2015-12-31 | $38,002,999 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2015-12-31 | $0 |
Total interest from all sources | 2015-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2015-12-31 | $298,965 |
Were there any nonexempt tranactions with any party-in-interest | 2015-12-31 | No |
Value of net income/loss | 2015-12-31 | $4,876,312 |
Value of net assets at end of year (total assets less liabilities) | 2015-12-31 | $37,069,515 |
Value of net assets at beginning of year (total assets less liabilities) | 2015-12-31 | $38,002,999 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2015-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2015-12-31 | No |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2015-12-31 | No |
Assets. Invements in employer securities at end of year | 2015-12-31 | $37,069,515 |
Assets. Invements in employer securities at beginning of year | 2015-12-31 | $38,002,999 |
Income. Dividends from common stock | 2015-12-31 | $298,965 |
Did the plan have assets held for investment | 2015-12-31 | Yes |
Aggregate proceeds on sale of assets | 2015-12-31 | $6,745,448 |
Aggregate carrying amount (costs) on sale of assets | 2015-12-31 | $6,391,620 |
2014 : WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2014 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2014-12-31 | $2,934,019 |
Total unrealized appreciation/depreciation of assets | 2014-12-31 | $2,934,019 |
Total transfer of assets to this plan | 2014-12-31 | $281,902 |
Total transfer of assets from this plan | 2014-12-31 | $4,918,573 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $0 |
Total income from all sources (including contributions) | 2014-12-31 | $3,073,597 |
Total loss/gain on sale of assets | 2014-12-31 | $-173,467 |
Total of all expenses incurred | 2014-12-31 | $0 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2014-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2014-12-31 | $0 |
Value of total assets at end of year | 2014-12-31 | $38,002,999 |
Value of total assets at beginning of year | 2014-12-31 | $39,566,073 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2014-12-31 | $0 |
Total interest from all sources | 2014-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2014-12-31 | $313,045 |
Were there any nonexempt tranactions with any party-in-interest | 2014-12-31 | No |
Value of net income/loss | 2014-12-31 | $3,073,597 |
Value of net assets at end of year (total assets less liabilities) | 2014-12-31 | $38,002,999 |
Value of net assets at beginning of year (total assets less liabilities) | 2014-12-31 | $39,566,073 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2014-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2014-12-31 | No |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2014-12-31 | No |
Assets. Invements in employer securities at end of year | 2014-12-31 | $38,002,999 |
Assets. Invements in employer securities at beginning of year | 2014-12-31 | $39,566,073 |
Income. Dividends from common stock | 2014-12-31 | $313,045 |
Did the plan have assets held for investment | 2014-12-31 | Yes |
Aggregate proceeds on sale of assets | 2014-12-31 | $5,385,493 |
Aggregate carrying amount (costs) on sale of assets | 2014-12-31 | $5,558,960 |
2013 : WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2013 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2013-12-31 | $17,112,542 |
Total unrealized appreciation/depreciation of assets | 2013-12-31 | $17,112,542 |
Total transfer of assets to this plan | 2013-12-31 | $259,479 |
Total transfer of assets from this plan | 2013-12-31 | $4,695,833 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $0 |
Total income from all sources (including contributions) | 2013-12-31 | $18,777,525 |
Total loss/gain on sale of assets | 2013-12-31 | $1,330,618 |
Total of all expenses incurred | 2013-12-31 | $0 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2013-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2013-12-31 | $0 |
Value of total assets at end of year | 2013-12-31 | $39,566,073 |
Value of total assets at beginning of year | 2013-12-31 | $25,224,902 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2013-12-31 | $0 |
Total interest from all sources | 2013-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2013-12-31 | $334,365 |
Were there any nonexempt tranactions with any party-in-interest | 2013-12-31 | No |
Value of net income/loss | 2013-12-31 | $18,777,525 |
Value of net assets at end of year (total assets less liabilities) | 2013-12-31 | $39,566,073 |
Value of net assets at beginning of year (total assets less liabilities) | 2013-12-31 | $25,224,902 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2013-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2013-12-31 | No |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2013-12-31 | No |
Assets. Invements in employer securities at end of year | 2013-12-31 | $39,566,073 |
Assets. Invements in employer securities at beginning of year | 2013-12-31 | $25,224,902 |
Income. Dividends from common stock | 2013-12-31 | $334,365 |
Did the plan have assets held for investment | 2013-12-31 | Yes |
Aggregate proceeds on sale of assets | 2013-12-31 | $5,249,586 |
Aggregate carrying amount (costs) on sale of assets | 2013-12-31 | $3,918,968 |
2012 : WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2012 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2012-12-31 | $7,565,036 |
Total unrealized appreciation/depreciation of assets | 2012-12-31 | $7,565,036 |
Total transfer of assets to this plan | 2012-12-31 | $206,559 |
Total transfer of assets from this plan | 2012-12-31 | $4,228,728 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2012-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2012-12-31 | $0 |
Total income from all sources (including contributions) | 2012-12-31 | $8,828,545 |
Total loss/gain on sale of assets | 2012-12-31 | $897,316 |
Total of all expenses incurred | 2012-12-31 | $0 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2012-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2012-12-31 | $0 |
Value of total assets at end of year | 2012-12-31 | $25,224,902 |
Value of total assets at beginning of year | 2012-12-31 | $20,418,526 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2012-12-31 | $0 |
Total interest from all sources | 2012-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2012-12-31 | $366,193 |
Were there any nonexempt tranactions with any party-in-interest | 2012-12-31 | No |
Value of net income/loss | 2012-12-31 | $8,828,545 |
Value of net assets at end of year (total assets less liabilities) | 2012-12-31 | $25,224,902 |
Value of net assets at beginning of year (total assets less liabilities) | 2012-12-31 | $20,418,526 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2012-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2012-12-31 | No |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2012-12-31 | No |
Assets. Invements in employer securities at end of year | 2012-12-31 | $25,224,902 |
Assets. Invements in employer securities at beginning of year | 2012-12-31 | $20,418,526 |
Income. Dividends from common stock | 2012-12-31 | $366,193 |
Did the plan have assets held for investment | 2012-12-31 | Yes |
Aggregate proceeds on sale of assets | 2012-12-31 | $4,782,063 |
Aggregate carrying amount (costs) on sale of assets | 2012-12-31 | $3,884,747 |
2011 : WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2011 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2011-12-31 | $-1,772,819 |
Total unrealized appreciation/depreciation of assets | 2011-12-31 | $-1,772,819 |
Total transfer of assets to this plan | 2011-12-31 | $26,432,651 |
Total transfer of assets from this plan | 2011-12-31 | $4,827,185 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2011-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2011-12-31 | $0 |
Total income from all sources (including contributions) | 2011-12-31 | $-1,186,940 |
Total loss/gain on sale of assets | 2011-12-31 | $180,571 |
Total of all expenses incurred | 2011-12-31 | $0 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2011-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2011-12-31 | $0 |
Value of total assets at end of year | 2011-12-31 | $20,418,526 |
Value of total assets at beginning of year | 2011-12-31 | $0 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2011-12-31 | $0 |
Total interest from all sources | 2011-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2011-12-31 | $405,308 |
Were there any nonexempt tranactions with any party-in-interest | 2011-12-31 | No |
Value of net income/loss | 2011-12-31 | $-1,186,940 |
Value of net assets at end of year (total assets less liabilities) | 2011-12-31 | $20,418,526 |
Value of net assets at beginning of year (total assets less liabilities) | 2011-12-31 | $0 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2011-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2011-12-31 | No |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2011-12-31 | No |
Assets. Invements in employer securities at end of year | 2011-12-31 | $20,418,526 |
Assets. Invements in employer securities at beginning of year | 2011-12-31 | $0 |
Income. Dividends from common stock | 2011-12-31 | $405,308 |
Did the plan have assets held for investment | 2011-12-31 | Yes |
Aggregate proceeds on sale of assets | 2011-12-31 | $5,362,225 |
Aggregate carrying amount (costs) on sale of assets | 2011-12-31 | $5,181,654 |
2022: WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2022 form 5500 responses | ||
---|---|---|
2022-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2022-01-01 | Submission has been amended | No |
2022-01-01 | This submission is the final filing | No |
2022-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2022-01-01 | Plan is a collectively bargained plan | No |
2021: WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2021 form 5500 responses | ||
2021-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2021-01-01 | Submission has been amended | No |
2021-01-01 | This submission is the final filing | No |
2021-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2021-01-01 | Plan is a collectively bargained plan | No |
2020: WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2020 form 5500 responses | ||
2020-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2020-01-01 | Submission has been amended | No |
2020-01-01 | This submission is the final filing | No |
2020-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2020-01-01 | Plan is a collectively bargained plan | No |
2019: WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2019 form 5500 responses | ||
2019-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2019-01-01 | Submission has been amended | No |
2019-01-01 | This submission is the final filing | No |
2019-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2019-01-01 | Plan is a collectively bargained plan | No |
2018: WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2018 form 5500 responses | ||
2018-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2018-01-01 | Submission has been amended | No |
2018-01-01 | This submission is the final filing | No |
2018-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2018-01-01 | Plan is a collectively bargained plan | No |
2017: WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2017 form 5500 responses | ||
2017-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2017-01-01 | Submission has been amended | No |
2017-01-01 | This submission is the final filing | No |
2017-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2017-01-01 | Plan is a collectively bargained plan | No |
2016: WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2016 form 5500 responses | ||
2016-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2016-01-01 | Submission has been amended | No |
2016-01-01 | This submission is the final filing | No |
2016-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2016-01-01 | Plan is a collectively bargained plan | No |
2015: WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2015 form 5500 responses | ||
2015-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2015-01-01 | Submission has been amended | No |
2015-01-01 | This submission is the final filing | No |
2015-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2015-01-01 | Plan is a collectively bargained plan | No |
2014: WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2014 form 5500 responses | ||
2014-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2014-01-01 | Submission has been amended | No |
2014-01-01 | This submission is the final filing | No |
2014-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2014-01-01 | Plan is a collectively bargained plan | No |
2013: WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2013 form 5500 responses | ||
2013-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2013-01-01 | Submission has been amended | No |
2013-01-01 | This submission is the final filing | No |
2013-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2013-01-01 | Plan is a collectively bargained plan | No |
2012: WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2012 form 5500 responses | ||
2012-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2012-01-01 | Submission has been amended | No |
2012-01-01 | This submission is the final filing | No |
2012-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2012-01-01 | Plan is a collectively bargained plan | No |
2011: WEST PHARMACEUTICAL SERVICES, INC. STOCK FUND MASTER TRUST 2011 form 5500 responses | ||
2011-01-03 | Type of plan entity | DFE (Diect Filing Entity) |
2011-01-03 | First time form 5500 has been submitted | Yes |
2011-01-03 | Submission has been amended | No |
2011-01-03 | This submission is the final filing | No |
2011-01-03 | This return/report is a short plan year return/report (less than 12 months) | Yes |
2011-01-03 | Plan is a collectively bargained plan | No |